Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 865.22 | 1445 / 1445 | 100% | 36.45 | 183 / 183 |
lung | 100% | 1476.52 | 578 / 578 | 100% | 31.81 | 1154 / 1155 |
intestine | 100% | 830.46 | 966 / 966 | 100% | 30.97 | 526 / 527 |
bladder | 100% | 722.24 | 21 / 21 | 100% | 29.11 | 502 / 504 |
thymus | 100% | 759.82 | 652 / 653 | 100% | 24.89 | 603 / 605 |
breast | 100% | 896.55 | 459 / 459 | 99% | 21.64 | 1112 / 1118 |
stomach | 99% | 514.08 | 357 / 359 | 100% | 30.79 | 286 / 286 |
uterus | 100% | 656.74 | 170 / 170 | 99% | 35.70 | 456 / 459 |
prostate | 100% | 541.31 | 245 / 245 | 97% | 12.16 | 488 / 502 |
kidney | 100% | 763.91 | 89 / 89 | 96% | 31.46 | 869 / 901 |
skin | 100% | 775.30 | 1805 / 1809 | 96% | 41.33 | 455 / 472 |
adrenal gland | 100% | 501.34 | 257 / 258 | 91% | 14.79 | 209 / 230 |
ovary | 81% | 257.94 | 145 / 180 | 96% | 16.91 | 413 / 430 |
pancreas | 66% | 179.58 | 217 / 328 | 98% | 45.29 | 175 / 178 |
liver | 70% | 184.88 | 159 / 226 | 90% | 17.04 | 364 / 406 |
brain | 58% | 153.03 | 1545 / 2642 | 71% | 16.52 | 503 / 705 |
adipose | 100% | 1018.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.27 | 29 / 29 |
spleen | 100% | 1165.69 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 37.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.20 | 1 / 1 |
heart | 100% | 1034.16 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1255.19 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2068.27 | 913 / 929 | 0% | 0 | 0 / 0 |
muscle | 86% | 247.30 | 691 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 51% | 7.09 | 41 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0009986 | Cellular component | cell surface |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD58 |
Protein name | CD58 antigen, (Lymphocyte function-associated antigen 3), isoform CRA_c (CD58 molecule) CD58 molecule CD58 protein Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD antigen CD58) |
Synonyms | hCG_37075 LFA3 |
Description | FUNCTION: Ligand of the T-lymphocyte CD2 glycoprotein. This interaction is important in mediating thymocyte interactions with thymic epithelial cells, antigen-independent and -dependent interactions of T-lymphocytes with target cells and antigen-presenting cells and the T-lymphocyte rosetting with erythrocytes. In addition, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells. |
Accessions | ENST00000369489.10 [P19256-1] B1AMW1 H0YDI1 ENST00000464088.5 [P19256-2] P19256 ENST00000526981.1 Q9BRW0 ENST00000457047.6 [P19256-3] ENST00000369487.3 |